Chinese General Practice ›› 2022, Vol. 25 ›› Issue (25): 3075-3082.DOI: 10.12114/j.issn.1007-9572.2022.0515
Special Issue: 神经退行性病变最新文章合辑; 述评栏目最新文章合辑
• Editorial • Next Articles
Received:
2022-07-14
Revised:
2022-07-18
Published:
2022-09-05
Online:
2022-07-21
Contact:
Wannian LIANG
About author:
通讯作者:
梁万年
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0515
行动领域 | 英国 | 英国北爱尔兰地区 | 澳大利亚 | 卢森堡 | 以色列 | 芬兰 | 爱尔兰 | 希腊 | 意大利 | 美国 | 挪威 | 马耳他 | 韩国 | 印度尼西亚 | 古巴 | 奥地利 | 斯洛文尼亚 | 瑞士 | 英国苏格兰地区 | WHO | 加拿大 | 威尔士 | 丹麦 | 卡塔尔 | 捷克 | 荷兰 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
预防 | 失智症友好意识 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | - | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ |
减少危险因素,推迟失智症的发生 | - | √ | - | √ | - | - | - | √ | √ | √ | √ | - | √ | √ | - | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
发布失智症国家(地区)框架和标准策略 | √ | √ | - | - | √ | - | - | - | - | - | - | √ | - | - | - | √ | - | √ | √ | - | - | - | - | √ | √ | √ | |
失智症作为公共卫生优先事项 | - | - | - | √ | √ | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | √ | - | - | √ | - | - | |
识别和描述早期认知障碍 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | - | - | - | - | |
基于社区的预防和管理 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | |
促进大脑健康 | - | - | - | - | - | √ | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | |
干预 | 失智症诊断、治疗、照护及干预 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | - | √ | √ | √ | √ | √ | √ | - | √ | - | - |
减少不适当的抗精神病药物处方 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | |
失智症患者的注册、分类管理 | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
对有失踪风险的患者做出快速响应 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
研究 | 建设失智症信息系统 | - | - | - | √ | - | - | √ | √ | √ | √ | - | - | - | √ | - | √ | √ | √ | √ | √ | - | - | - | √ | - | √ |
失智症研究、教育和创新 | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
患者在社会建筑环境中生活得更好 | √ | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | √ | - | - | √ | - | - | √ | - | |
开发卫生和社会福利技术 | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
技术的可获得性 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
支持 | 对失智症照料者的支持 | - | √ | - | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
扩大不同护理服务主体的协调与合作 | - | - | - | - | - | - | - | - | √ | - | √ | - | - | √ | - | √ | - | - | √ | - | - | - | √ | √ | √ | √ | |
提高照护人员专业发展 | - | - | - | - | - | - | - | - | √ | - | - | √ | - | √ | √ | - | - | - | - | - | - | - | - | - | - | √ | |
确保患者和护理人员的参与性和自主性 | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | - | √ | - | - | - | - | - | - | - | |
实施 | 建立战略领导管理小组 | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | √ |
保障行动计划实施所需资源 | - | √ | - | - | - | - | - | - | - | √ | - | √ | - | √ | - | - | - | - | √ | - | - | √ | √ | √ | |||
优化利益相关者的作用 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | √ | - | - | - | - | - | - | - | |
立法 | 护理人员的道德和赋权 | - | - | - | √ | - | - | - | - | √ | - | - | √ | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - |
保护失智症患者的权益 | - | √ | - | √ | - | - | - | √ | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | √ | √ | - | |
评估 | 持续护理、临终支持的质量 | - | √ | √ | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | √ | - | √ | √ | √ | √ | - | √ |
服务的经济可持续性 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | √ | - | - | - | - | √ | - | √ | - | |
结果完成情况、时间进度 | - | - | - | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | - | √ |
Table 1 Priorities in the action plans on dementia from the WHO and 25 countries/regions
行动领域 | 英国 | 英国北爱尔兰地区 | 澳大利亚 | 卢森堡 | 以色列 | 芬兰 | 爱尔兰 | 希腊 | 意大利 | 美国 | 挪威 | 马耳他 | 韩国 | 印度尼西亚 | 古巴 | 奥地利 | 斯洛文尼亚 | 瑞士 | 英国苏格兰地区 | WHO | 加拿大 | 威尔士 | 丹麦 | 卡塔尔 | 捷克 | 荷兰 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
预防 | 失智症友好意识 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | - | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ |
减少危险因素,推迟失智症的发生 | - | √ | - | √ | - | - | - | √ | √ | √ | √ | - | √ | √ | - | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
发布失智症国家(地区)框架和标准策略 | √ | √ | - | - | √ | - | - | - | - | - | - | √ | - | - | - | √ | - | √ | √ | - | - | - | - | √ | √ | √ | |
失智症作为公共卫生优先事项 | - | - | - | √ | √ | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | √ | - | - | √ | - | - | |
识别和描述早期认知障碍 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | - | - | - | - | |
基于社区的预防和管理 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | |
促进大脑健康 | - | - | - | - | - | √ | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | |
干预 | 失智症诊断、治疗、照护及干预 | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | - | √ | √ | √ | √ | √ | √ | - | √ | - | - |
减少不适当的抗精神病药物处方 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | √ | - | - | - | - | - | - | - | |
失智症患者的注册、分类管理 | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
对有失踪风险的患者做出快速响应 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
研究 | 建设失智症信息系统 | - | - | - | √ | - | - | √ | √ | √ | √ | - | - | - | √ | - | √ | √ | √ | √ | √ | - | - | - | √ | - | √ |
失智症研究、教育和创新 | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
患者在社会建筑环境中生活得更好 | √ | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | √ | - | - | √ | - | - | √ | - | |
开发卫生和社会福利技术 | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
技术的可获得性 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | |
支持 | 对失智症照料者的支持 | - | √ | - | √ | √ | √ | √ | √ | √ | √ | - | √ | √ | - | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
扩大不同护理服务主体的协调与合作 | - | - | - | - | - | - | - | - | √ | - | √ | - | - | √ | - | √ | - | - | √ | - | - | - | √ | √ | √ | √ | |
提高照护人员专业发展 | - | - | - | - | - | - | - | - | √ | - | - | √ | - | √ | √ | - | - | - | - | - | - | - | - | - | - | √ | |
确保患者和护理人员的参与性和自主性 | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | √ | - | - | √ | - | - | - | - | - | - | - | |
实施 | 建立战略领导管理小组 | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | - | - | √ |
保障行动计划实施所需资源 | - | √ | - | - | - | - | - | - | - | √ | - | √ | - | √ | - | - | - | - | √ | - | - | √ | √ | √ | |||
优化利益相关者的作用 | - | - | - | - | - | - | - | - | - | - | - | - | - | √ | - | - | - | - | √ | - | - | - | - | - | - | - | |
立法 | 护理人员的道德和赋权 | - | - | - | √ | - | - | - | - | √ | - | - | √ | - | - | - | - | √ | - | √ | - | - | - | - | - | - | - |
保护失智症患者的权益 | - | √ | - | √ | - | - | - | √ | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | √ | √ | - | |
评估 | 持续护理、临终支持的质量 | - | √ | √ | - | - | - | - | - | - | √ | - | - | - | - | - | - | - | - | √ | - | √ | √ | √ | √ | - | √ |
服务的经济可持续性 | - | - | - | - | - | - | - | - | - | - | √ | - | √ | - | - | - | - | √ | - | - | - | - | √ | - | √ | - | |
结果完成情况、时间进度 | - | - | - | - | - | - | - | - | √ | √ | - | - | - | √ | - | - | - | - | - | - | - | - | - | √ | - | √ |
[1] |
中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会.中国阿尔茨海默病一级预防指南[J].中华医学杂志,2020,100(35):2721-2735. DOI:10.3760/cma.j.cn112137-20200702-02017.
|
[2] |
|
[3] |
郑远长. 关于我国失智老年人研究工作综述及相关数据的比较分析[J]. 社会福利(理论版),2021,30(2):3-15.
|
[4] |
World Health Organization. Global status report on the public health response to dementia[R]. Geneva:World Health Organization,2021.
|
[5] |
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050:an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health,2022,7(2):e105-125. DOI:10.1016/s2468-2667(21)00249-8.
|
[6] | |
[7] |
Alzheimer's Disease International. Dementia statistics[EB/OL]. [2022-02-01].
|
[8] |
World Health Organization. Global action plan on the public health response to dementia 2017—2025[R]. Geneva:World Health Organization,2017.
|
[9] |
Australian Government Department of Health. National framework for action on dementia 2015—2019[EB/OL]. [2022-02-03].
|
[10] |
Ministry of Health and Welfare. The Third National Dementia Plan in Korea:living well with dementia in the community[EB/OL]. [2022-02-05].
|
[11] |
Department of Health. Living well with dementia:a National Dementia Strategy[M]. London:Department of Health,2009.
|
[12] |
Finnish Ministry of Social Affairs and Health. National Memory Programme 2012—2020. Creating a "memory-friendly" Finland[EB/OL]. (2013-03-23)[2022-02-10].
|
[13] |
Danish Ministry of Health. A safe and dignified life with dementia:national action plan on dementia 2025[EB/OL]. [2022-02-15].
|
[14] |
Ministry of Health of the Czech Republic. National Action Plan for Alzheimer's disease and other similar diseases 2020—2030[EB/OL]. [2022-03-10].
|
[15] |
U.S. Department of Health and Human Services. National Plan to Address Alzheimer's disease:2019 update[EB/OL]. [2022-02-20].
|
[16] |
|
[17] |
Public Health Agency of Canada. A dementia strategy for Canada:together we aspire(2019)[EB/OL]. [2022-03-11].
|
[18] |
Ministry of Health Republic of Indonesia. National strategy management of Alzheimer and other dementia diseases:towards healthy and productive older persons[EB/OL]. [2022-03-11].
|
[19] |
Ministry of Public Health. Qatar national dementia strategy summary 2018—2022[EB/OL]. [2022-03-11].
|
[20] |
Federal Ministry Labour,Social Affairs. Austria—dementia strategy:living well with dementia[EB/OL]. [2022-03-11].
|
[21] |
Dementia Oversight of Implementation and Impact Group. Dementia action plan for Wales 2018—2022[EB/OL]. (2018-02-14)[2022-03-11].
|
[22] |
Greek Republic,Ministry of Foreign Affairs. National action plan for dementia:Alzheimer's disease 2015—2020[EB/OL]. [2022-03-15].
|
[23] |
State of Israel Ministry of Health. Addressing Alzheimer's and other types of dementia:Israel national strategy[EB/OL]. [2022-03-15].
|
[24] |
Sottish Government. Scotland's national dementia strategy 2017—2020[EB/OL]. (2017-06-28)[2022-03-15].
|
[25] |
Federal Office of Public Health,Conference of Swiss State Health Directors. Switzerland national dementia strategy 2014—2019[EB/OL]. [2022-03-15].
|
[26] |
Luxembourg's Health and Family Ministries. National dementia action plan[EB/OL]. [2022-03-15].
|
[27] |
Norwegian Ministry of Health and Care Services. Norway-dementia plan 2015—2020[EB/OL].[2022-03-15].
|
[28] |
The Alzheimer Society of Ireland. Ireland-national dementia strategy 2011—2016[EB/OL].[2022-03-15].
|
[29] |
Ministry of Health,Welfare and Sport. National dementia strategy 2021—2030[EB/OL].[2022-03-15].
|
[30] |
Parliamentary Secretariat for Rights of Persons with Disability and Active Ageing. Malta-empowering change 2015—2023[EB/OL].[2022-03-15].
|
[31] |
Ministry of Health. National dementia strategy 2014[EB/OL].[2022-03-15].
|
[32] |
Slovenia. National Plan 2016—2020[EB/OL].[2022-03-15].
|
[33] |
宁吉喆. 第七次全国人口普查主要数据情况[J]. 中国统计,2021,69(5):4-5.
|
[34] |
|
[35] |
|
[36] |
|
[37] |
国家卫生健康委办公厅关于探索开展抑郁症、老年痴呆防治特色服务工作的通知[A/OL]. [2022-04-05].
|
[38] |
|
[39] |
World Health Organization. Risk reduction of cognitive decline and dementia WHO guidelines,2019[EB/OL]. [2022-04-05].
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[4] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[5] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[6] | LIAO Kexin, XIAO Yisheng. Effects of the Compatibility Extract of Huangjing Pill on the Hippocampal DG Region Stem Cells in Rats with Learning and Memory Impairments [J]. Chinese General Practice, 2025, 28(24): 3019-3025. |
[7] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[8] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[9] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[10] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[11] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[12] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[13] | WEN Yongxia, SUN Hai, CHEN Xiaoju, CAI Wanjing, LI Shuni, GUO Honghua. A Systematic Review of the Assessment Tools for Maternal Psychological Birth Trauma [J]. Chinese General Practice, 2025, 28(20): 2555-2561. |
[14] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[15] | ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin. Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine [J]. Chinese General Practice, 2025, 28(18): 2294-2300. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||